Criteria Bio Ventures — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

NRG Therapeuticsnrgtherapeutics.com inSep 2025 · $67M✓ verified

NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's.

BiotechHealthtechLongevity

Neil Miller(CEO)inRichard Rutter(CSO)inGrant Hawthorne(COO)inClaus Sundgreen(Chief Medical Officer)inPaul Thompson(CDO)in

BoardJonathan Savidge(Independent Non Executive Chair)

Co-investorsBrandon Capital Novartis Venture Fund SV Health Investors British Business Bank M Ventures Dementia Discovery Fund +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.